Independent Survey Conducted on Information Quality and Domestic Utilization of Overseas AI-Powered Skin Analysis Devices | Verification of Awareness of Multi-faceted Skin Analysis Systems such as Skin Analyzer Pro-A
MEDLAC Instrument and Consulting Inc. has announced the results of an independent survey on the information quality and domestic utilization of overseas AI-powered skin analysis devices in Japanese clinics. The survey aims to provide objective technical information for domestic doctors considering the introduction of such devices.
📋 Article Processing Timeline
- 📰 Published: April 25, 2026 at 03:00
- 🔍 Collected: April 24, 2026 at 18:31
- 🤖 AI Analyzed: April 24, 2026 at 19:38 (1h 6m after Collected)
※This release is an announcement regarding the summary of results from a survey independently conducted by our company.
※This does not recommend specific products, procedures, treatments, adoption decisions, or usage.
※The results of this survey are based on information independently collected and analyzed by our company, and do not guarantee specific efficacy, effectiveness, or safety in Japan.
※For individual adoption and usage decisions, please confirm the latest public information, relevant laws and regulations, legitimate materials from device providers, and other necessary information, and make your own judgment.
MEDLAC Instrument and Consulting Inc. (Headquarters: Fukuoka City, Fukuoka Prefecture; Representative Director: Hideki Ogawa) has conducted an independent survey on the information quality of overseas AI-powered skin analysis devices and their utilization status in domestic clinics, and will announce the results.
## Background of the Survey
In recent years, skin analysis devices combining AI (artificial intelligence) technology and high-resolution imaging have attracted attention in the field of aesthetic medicine. These devices, by quantifying and visualizing skin conditions from multiple angles, enable objective data provision for pre- and post-treatment evaluation and counseling, and their adoption is progressing mainly overseas.
On the other hand, when domestic medical institutions introduce and operate such overseas-made skin analysis devices, there is a current situation where technical evaluation information, such as the reliability of AI analysis algorithms, the accuracy of analysis through multi-angle photography (front, 45-degree side, etc.), and differences in photography methods using polarized light filter (CPL) technology, is not sufficiently organized.
As a provider of information on overseas medical devices, our company conducted this survey with the aim of organizing and providing objective technical information necessary for domestic doctors when considering the introduction of skin analysis devices.
## Overview of Survey Results
This survey verified and analyzed the following three items:
- ① Information Needs Survey on Data Objectivity in Skin Analysis Devices
We conducted interviews with doctors at domestic clinics regarding what information they prioritize concerning the objectivity and reproducibility of scores and data output by skin analysis devices.
Specifically, we confirmed needs regarding the reliability of AI analysis algorithms, variations in results due to shooting environment, and simultaneous evaluation of multiple areas (sensitivity, pigmentation, skin quality, aging, etc.).
As a result, trends in information needs regarding the objectivity of skin data were confirmed.
- ② Survey on Utilization Status as an Evaluation Tool for Pre- and Post-Treatment
We conducted a questionnaire survey with domestic doctors regarding their needs for utilizing AI-powered skin analysis devices, which have USFDA-certified manufacturing data disclosed by a Taiwanese corporation, as a comparative evaluation tool for pre- and post-treatment.
As a result, data on the direction of utilization needs for skin analysis data in pre- and post-treatment evaluation was obtained.
- ③ Hearing on Awareness of Technical Specifications of AI-Powered Skin Analysis Devices (e.g., Skin Analyzer Pro-A)
Based on USFDA-certified manufacturing data disclosed from Taiwan, we confirmed the awareness of domestic doctors regarding the technical specifications of AI-powered skin analysis devices.
Specifically, we conducted hearings on the understanding of technical specifications such as multi-angle analysis through simultaneous three-direction photography (front, left 45 degrees, right 45 degrees), detailed observation of the skin surface using CPL (polarized light filter) technology, and AI algorithm-based aging simulation functions.
As a result, data on the awareness of technical specifications of AI-powered skin analysis devices was obtained.
## Future Outlook
Since its establishment in 2019, our company has continuously interviewed domestic doctors about their needs regarding overseas medical devices.
This survey, as part of that accumulation, was prompted by a survey request from a Taiwanese corporation regarding USFDA-approved devices, and involved collecting and analyzing doctors' opinions on the suitability of AI-powered skin analysis devices for the Japanese market.
For detailed analysis results of each survey item, please contact our company.
Our company will continue to work on improving the transparency of information regarding overseas medical devices through the accumulation and disclosure of objective data.
## Survey Overview
- Item
- Content
- Survey Period
January 15, 2025 - March 31, 2026
- Survey Organization (Survey Principal)
MEDLAC Instrument and Consulting Inc. (MEDLAC, Inc.) Research and Development Department
- Survey Target
Doctors and clinic directors in domestic clinics who have previously used our overseas medical device provision support services
- Valid Responses (Sample Response Count)
32 experienced doctors (number of doctors actually interviewed or surveyed)
- Survey Method
- ① Data Objectivity Survey: Face-to-face interviews on information needs regarding the objectivity and reproducibility of scores and data output by AI-powered skin analysis devices
- ② Utilization Status Survey: AI-powered skin analysis devices with USFDA-certified manufacturing data
- Keywords:
※This does not recommend specific products, procedures, treatments, adoption decisions, or usage.
※The results of this survey are based on information independently collected and analyzed by our company, and do not guarantee specific efficacy, effectiveness, or safety in Japan.
※For individual adoption and usage decisions, please confirm the latest public information, relevant laws and regulations, legitimate materials from device providers, and other necessary information, and make your own judgment.
MEDLAC Instrument and Consulting Inc. (Headquarters: Fukuoka City, Fukuoka Prefecture; Representative Director: Hideki Ogawa) has conducted an independent survey on the information quality of overseas AI-powered skin analysis devices and their utilization status in domestic clinics, and will announce the results.
## Background of the Survey
In recent years, skin analysis devices combining AI (artificial intelligence) technology and high-resolution imaging have attracted attention in the field of aesthetic medicine. These devices, by quantifying and visualizing skin conditions from multiple angles, enable objective data provision for pre- and post-treatment evaluation and counseling, and their adoption is progressing mainly overseas.
On the other hand, when domestic medical institutions introduce and operate such overseas-made skin analysis devices, there is a current situation where technical evaluation information, such as the reliability of AI analysis algorithms, the accuracy of analysis through multi-angle photography (front, 45-degree side, etc.), and differences in photography methods using polarized light filter (CPL) technology, is not sufficiently organized.
As a provider of information on overseas medical devices, our company conducted this survey with the aim of organizing and providing objective technical information necessary for domestic doctors when considering the introduction of skin analysis devices.
## Overview of Survey Results
This survey verified and analyzed the following three items:
- ① Information Needs Survey on Data Objectivity in Skin Analysis Devices
We conducted interviews with doctors at domestic clinics regarding what information they prioritize concerning the objectivity and reproducibility of scores and data output by skin analysis devices.
Specifically, we confirmed needs regarding the reliability of AI analysis algorithms, variations in results due to shooting environment, and simultaneous evaluation of multiple areas (sensitivity, pigmentation, skin quality, aging, etc.).
As a result, trends in information needs regarding the objectivity of skin data were confirmed.
- ② Survey on Utilization Status as an Evaluation Tool for Pre- and Post-Treatment
We conducted a questionnaire survey with domestic doctors regarding their needs for utilizing AI-powered skin analysis devices, which have USFDA-certified manufacturing data disclosed by a Taiwanese corporation, as a comparative evaluation tool for pre- and post-treatment.
As a result, data on the direction of utilization needs for skin analysis data in pre- and post-treatment evaluation was obtained.
- ③ Hearing on Awareness of Technical Specifications of AI-Powered Skin Analysis Devices (e.g., Skin Analyzer Pro-A)
Based on USFDA-certified manufacturing data disclosed from Taiwan, we confirmed the awareness of domestic doctors regarding the technical specifications of AI-powered skin analysis devices.
Specifically, we conducted hearings on the understanding of technical specifications such as multi-angle analysis through simultaneous three-direction photography (front, left 45 degrees, right 45 degrees), detailed observation of the skin surface using CPL (polarized light filter) technology, and AI algorithm-based aging simulation functions.
As a result, data on the awareness of technical specifications of AI-powered skin analysis devices was obtained.
## Future Outlook
Since its establishment in 2019, our company has continuously interviewed domestic doctors about their needs regarding overseas medical devices.
This survey, as part of that accumulation, was prompted by a survey request from a Taiwanese corporation regarding USFDA-approved devices, and involved collecting and analyzing doctors' opinions on the suitability of AI-powered skin analysis devices for the Japanese market.
For detailed analysis results of each survey item, please contact our company.
Our company will continue to work on improving the transparency of information regarding overseas medical devices through the accumulation and disclosure of objective data.
## Survey Overview
- Item
- Content
- Survey Period
January 15, 2025 - March 31, 2026
- Survey Organization (Survey Principal)
MEDLAC Instrument and Consulting Inc. (MEDLAC, Inc.) Research and Development Department
- Survey Target
Doctors and clinic directors in domestic clinics who have previously used our overseas medical device provision support services
- Valid Responses (Sample Response Count)
32 experienced doctors (number of doctors actually interviewed or surveyed)
- Survey Method
- ① Data Objectivity Survey: Face-to-face interviews on information needs regarding the objectivity and reproducibility of scores and data output by AI-powered skin analysis devices
- ② Utilization Status Survey: AI-powered skin analysis devices with USFDA-certified manufacturing data
- Keywords: